PAN-Seratech GmbH

Business Strategies

PAN‐Seratech's core business is the development, production and distribution of a broad variety of innovative biotechnological products all around the cell culture. Our business strategy is to develop new products, services and processes to make cell cultivation in research and industry safer, easier and cheaper. The core business include animal sera of all kinds for the research and development of cell cultures. Industrial applications include, among other vaccine production, the production of monoclonal antibodies, and more.

Core Technologies and Services

PAN‐Seratech produces animal products for laboratory and industrial use.
Key products of PAN‐Seratech are:

• Bovine sera
• FCS and special variants
• Human sera
• Other animal sera such as horse, pig etc.
• BSA and HSA

Distribution

Exclusive distributor partners in most important markets (Europe, Middle East, Asia)